Search results
Added:
3 years ago
A 2011 report from the American Heart Association states that “On the basis of 2007 mortality rate data, more than 2,200 Americans die of CVD every day, an average of 1 death every 39 seconds.”1 The economic cost of cardiovascular disease (CVD) in the US was nearly $286 billion in 2007, which is 15 % of total healthcare expenditure.
There are 13 million people living with a diagnosis of CVD.2…
View more
Added:
11 months ago
ESC-HFA 2023 — Prof Domingo Pascual Figal (Hospital Clinico Universitario Virgen de la Arrixaca, SP) discusses the DAPA MODA study (NCT04707352).
The study aimed to assess the effects of dapagliflozin on cardiac remodeling parameters, particularly LA geometry and function, and biomarkers reflecting pathophysiological pathways. Findings from ESC Heart Failure 2023 revealed that dapagliflozin…
View more
Added:
2 years ago
In this video, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, Los Angeles, CA, US) provides her expert opinion on the 2022 ACC guidelines for the management of Heart Failure. Dr Kittleson outlines the applicability of these recommendations, as well as the barriers and opportunities.
Recorded remotely from Beverley-Hills, 2022.
Interviewer: Mirjam Boros
View more
Added:
3 years ago
Both the art and the science of echocardiography have made tremendous strides in the 50 years since their earliest origins. In its modern-day form, echocardiography maintains a legacy of bedside utility while adopting many of the technologic advances ushered in by the digital era. As a result, it boasts a broad and growing spectrum of application including routine use in primary cardiac diagnosis…
View more
Added:
3 years ago
Cardiovascular disease (CVD) is the most common cause of death worldwide.1 With an estimated 7.6 million global deaths due to coronary heart disease in 2005,2 the size of the burden placed on society cannot be understated. Acute myocardial infarction (AMI), the classic ‘heart attack,’ will be the classification given to many of these deaths. In its most life-threatening form, AMI is identified…
View more
Added:
3 years ago
Complex intra-cardiac anatomy and spatial relationships are inherent to congenital heart defects (CHD). Until recently, our ability to image the heart by echocardiography has been limited to two-dimensional (2-D) techniques. Advances in transducer technology, beamforming, and computer processing power and speed have led to significant improvements in spatial and temporal resolution using 2-D…
View more
Added:
3 years ago
Heart failure is the only cardiovascular disease with increasing incidence and mortality.1 Approximately five million Americans have heart failure, with an annual incidence of 10 per 1,000 in individuals over 65 years of age, an already rising demographic segment of society. Heart failure is the most frequent Medicare diagnosis, with most of its cost related to hospitalizations.1,2 Identification…
View more
Added:
3 years ago
Contrast-enhanced ultrasound imaging (CEUS) is a non-invasive imaging modality that utilizes air-filled microspheres as blood pool agents, which act as intravascular indicators, resulting in improved accuracy and reliability in performing ultrasound images of the heart. CEUS is increasingly used throughout the US, South America, Australia, the Middle East, Europe, Japan, Canada, and Asia as a…
View more
Added:
3 years ago
A significant proportion of patients for whom statins are prescribed discontinue their therapy or take it incorrectly. Large cohort studies in a variety of settings have confirmed high rates of discontinuation of lipid lowering therapies and poor adherence to drug regimens.1-5 Not suprisingly, there is a failure to reach targets for lipid lowering in current practice.6 Further, nonadherence has…
View more
Added:
3 years ago
The complications of atherosclerotic disease comprise the primary cause of mortality in the world today. Acute complications such as sudden cardiac death, myocardial infarction and stroke are typically due to the formation of a intra-arterial thrombus at the site of a rupture or erosion of an atherosclerotic lesion, with platelet activation and aggregation central to thrombus formation. Aspirin,…
View more
